LifeVantage logo

LFVN - LifeVantage Share Price

$12.55 -0.2  -1.5%

Last Trade - 24/09/20

Small Cap
Market Cap £141.3m
Enterprise Value £123.9m
Revenue £182.7m
Position in Universe 3806th / 6400
Unlock LFVN Revenue
Relative Strength (%)
1m -8.68%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -27.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
190.3 206.5 199.5 203.2 226 232.9 245.8 256.8 +4.1%
-29.5 -5.2 -76.1 +344.4 -1.6 +58.2 +13.8 +11.1
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, LifeVantage Corp revenues increased 3% to $232.9M. Net income increased 55% to $11.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Selling, general and administrative decrease of 2% to $67.9M (expense), Interest expense decrease of 63% to $120K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for LFVN
Graphical History


LFVN Revenue Unlock LFVN Revenue

Net Income

LFVN Net Income Unlock LFVN Revenue

Normalised EPS

LFVN Normalised EPS Unlock LFVN Revenue

PE Ratio Range

LFVN PE Ratio Range Unlock LFVN Revenue

Dividend Yield Range

LFVN Dividend Yield Range Unlock LFVN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LFVN EPS Forecasts Unlock LFVN Revenue
Profile Summary

LifeVantage Corporation is focused on bio-hacking the aging code through nutrigenomics. The Company is helping people their health, wellness and financial independence goals. The Company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim Nrf2 synergizer, Protandim NRF1 synergizer, LifeVantage TrueScience, Petandim for dogs, and Axio. It sells products in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands and Germany.

Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated March 9, 2018
Public Since September 12, 2012
No. of Shareholders: 86
No. of Employees: 247
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 14,354,085
Free Float (0.0%)
Eligible for
LFVN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for LFVN
Upcoming Events for LFVN
Wednesday 28th October, 2020 Estimate
Q1 2021 LifeVantage Corp Earnings Release
Friday 4th December, 2020 Estimate
LifeVantage Corp Annual Shareholders Meeting
Tuesday 26th January, 2021 Estimate
Q2 2021 LifeVantage Corp Earnings Release
Frequently Asked Questions for LifeVantage
What is the LifeVantage share price?

As of 24/09/20, shares in LifeVantage are trading at $12.55, giving the company a market capitalisation of £141.3m. This share price information is delayed by 15 minutes.

How has the LifeVantage share price performed this year?

Shares in LifeVantage are currently trading at $12.55 and the price has moved by -14.04% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the LifeVantage price has moved by -20.93% over the past year.

What are the analyst and broker recommendations for LifeVantage?

Of the analysts with advisory recommendations for LifeVantage, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for LifeVantage is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will LifeVantage next release its financial results?

LifeVantage is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the LifeVantage dividend yield?

LifeVantage does not currently pay a dividend.

Does LifeVantage pay a dividend?

LifeVantage does not currently pay a dividend.

When does LifeVantage next pay dividends?

LifeVantage does not currently pay a dividend.

How do I buy LifeVantage shares?

To buy shares in LifeVantage you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of LifeVantage?

Shares in LifeVantage are currently trading at $12.55, giving the company a market capitalisation of £141.3m.

Where are LifeVantage shares listed? Where are LifeVantage shares listed?

Here are the trading details for LifeVantage:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: LFVN
What kind of share is LifeVantage?

Based on an overall assessment of its quality, value and momentum, LifeVantage is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a LifeVantage share price forecast 2020?

Shares in LifeVantage are currently priced at $12.55. At that level they are trading at 59.36% discount to the analyst consensus target price of 0.00.

Analysts covering LifeVantage currently have a consensus Earnings Per Share (EPS) forecast of 0.9 for the next financial year.

How can I tell whether the LifeVantage share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LifeVantage. Over the past six months, the relative strength of its shares against the market has been -0.35%. At the current price of $12.55, shares in LifeVantage are trading at -9.47% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the LifeVantage PE Ratio?

The LifeVantage PE ratio based on its reported earnings over the past 12 months is 15.87. The shares are currently trading at $12.55.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of LifeVantage?

We were unable to find the directors for LifeVantage.

Who are the major shareholders of LifeVantage?

Here are the top five shareholders of LifeVantage based on the size of their shareholding:

Renaissance Technologies LLC Hedge Fund
Percentage owned: 8.02% (1.15m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.28% (1.05m shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 6.22% (892k shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.66% (812k shares)
Acadian Asset Management LLC Investment Advisor/Hedge Fund
Percentage owned: 3.69% (529k shares)
Similar to LFVN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.